Welcome to our dedicated page for ZENA news (Ticker: ZENA), a resource for investors and traders seeking the latest updates and insights on ZENA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ZENA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ZENA's position in the market.
ZenaTech (Nasdaq: ZENA), an AI drone solutions and enterprise SaaS company, has announced the approval to list its common shares on the Nasdaq Capital Market. Trading is expected to commence on October 1st, 2024, under the ticker symbol 'ZENA'.
CEO Dr. Shaun Passley Ph.D. stated that this listing is a significant achievement for ZenaTech and will help advance the development of their drone solutions for various applications. The company believes that accessing public capital markets will act as a growth catalyst, enabling organic growth, strategic acquisitions, and acceleration of ZenaDrone manufacturing and distribution plans.
Maxim Group served as the exclusive financial advisor for the direct listing. A prospectus related to the registration statement is available on the SEC website and in the Investors section of ZenaTech's website.
